APIDRA SOLOSTAR 100 UNIT/ML
FDA nonproprietary name: insulin glulisine
For 15 mL
Pharmacies pay
$157.52 filed
15 × $10.50102 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$154.93 filed
15 × $10.32858 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.98× estimated
Medicare paid about what pharmacies pay.
Part D averages every strength and form sold under “Apidra Solostar” / “Insulin Glulisine” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$186.15 estimated
$157.52 + $23.63 (15%) + $5.00 fee per fill = $186.15
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
APIDRA SOLOSTAR 100 UNIT/ML is how the CMS NADAC file names this product. The FDA NDC Directory lists it as insulin glulisine, under the trade name “Apidra SoloStar”.
FDA gives its dosage form as injection, solution and its route as subcutaneous.
The labeler, the company named on the label, is sanofi-aventis U.S. LLC.
FDA’s Established Pharmacologic Class for it is Insulin Analog.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00088-2502-05.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $157.52 for 15 mL (15 × $10.50102 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
The NDC
- 00088-2502-05 · sanofi-aventis U.S. LLC · $10.50102 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
1 other product in the NADAC file shares the FDA nonproprietary name insulin glulisine with APIDRA SOLOSTAR 100 UNIT/ML.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| APIDRA 100 UNIT/ML VIAL | $8.16233 per ML filed | $7.99911 per ML filed |
| APIDRA SOLOSTAR 100 UNIT/ML this page | $10.50102 per ML filed | $10.32858 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
Its NADAC price is $10.50102 per ML filed.
Of the 56 other products in FDA’s Insulin Analog class priced per ML, 16 have a higher middle NADAC price and 40 a lower one. The one in the middle is TRESIBA FLEXTOUCH 100 UNIT/ML, at $9.03577 per ML filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $154.93 for 15 mL, at an average of $10.32858 per ML in 2024 (2024-01-01 to 2024-12-31) for “Apidra Solostar” and “Insulin Glulisine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 8,018 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 15 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 15 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for APIDRA SOLOSTAR 100 UNIT/ML labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Apidra Solostar / Insulin Glulisine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
- Why does this page start at 15 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 15 mL in one package for this product’s NDC (“5 SYRINGE, PLASTIC in 1 CARTON (0088-2502-05) / 3 mL in 1 SYRINGE, PLASTIC (0088-2502-00)”), so the card starts at one package: 15 ML. Change it to match your prescription.
Related pages
Its pharmacologic class
Related in the same class
- LANTUS SOLOSTAR 100 UNIT/ML
- NOVOLOG 100 UNIT/ML FLEXPEN
- HUMALOG 100 UNIT/ML KWIKPEN
- TRESIBA FLEXTOUCH 100 UNIT/ML
- FIASP 100 UNIT/ML FLEXTOUCH